Literature DB >> 15579517

Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients.

Angela Yee-Moon Wang1, Mandy Man-Mei Sea, Nelson Tang, John E Sanderson, Siu-Fai Lui, Philip Kam-Tao Li, Jean Woo.   

Abstract

Cardiovascular disease is the leading cause of death in ESRD patients and is strongly associated with malnutrition. The mechanism of malnutrition is not clear, but hypermetabolism is suggested to contribute to cardiac cachexia. This study examined resting energy expenditure (REE) in relation to the clinical outcomes of ESRD patients who receive continuous ambulatory peritoneal dialysis (CAPD) treatment. A prospective observational cohort study was performed in 251 CAPD patients. REE was measured at study baseline using indirect calorimetry together with other clinical, nutritional, and dialysis parameters. Patients were followed up for a mean +/- SD duration of 28.7 +/- 14.3 mo. REE was 39.1 +/- 9.6 and 40.1 +/- 9.0 kcal/kg fat-free edema-free body mass per day for men and women, respectively (P = 0.391). Using multiple regression analysis, fat-free edema-free body mass-adjusted REE was negatively associated with residual GFR (P < 0.001) and serum albumin (P = 0.046) and positively associated with diabetes (P = 0.002), cardiovascular disease (P = 0.009), and C-reactive protein (P = 0.009). At 2 yr, the overall survival was 63.3, 73.6, and 95.9% (P < 0.0001), and cardiovascular event-free survival was 72.3, 84.6, and 97.2% (P = 0.0003), respectively, for patients in the upper, middle, and lower tertiles of REE. Adjusting for age, gender, diabetes, and cardiovascular disease, patients in the upper and middle tertiles showed a 4.19-fold (95% confidence interval, 2.15 to 8.16; P < 0.001) and a 2.90-fold (95% confidence interval, 1.49, 5.63; P = 0.002) respective increase in the risk of all-cause mortality compared with those in the lower tertile. However, the significance of REE in predicting mortality was gradually reduced when additional adjustment was made for C-reactive protein, serum albumin, and residual GFR in a stepwise manner. In conclusion, a higher REE is associated with increased mortality and cardiovascular death in CAPD patients and is partly related to its close correlations with residual kidney function, cardiovascular disease, inflammation, and malnutrition in these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15579517     DOI: 10.1097/01.ASN.0000144206.29951.B2

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  26 in total

Review 1.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

2.  TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia.

Authors:  Kevin G Burfeind; Xinxia Zhu; Peter R Levasseur; Katherine A Michaelis; Mason A Norgard; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2018-05-28       Impact factor: 7.217

Review 3.  Energy homeostasis and cachexia in chronic kidney disease.

Authors:  Robert H Mak; Wai Cheung
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

4.  Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.

Authors:  Sarah A Reed; Pooja B Sandesara; Sarah M Senf; Andrew R Judge
Journal:  FASEB J       Date:  2011-11-18       Impact factor: 5.191

Review 5.  Inflammation and cachexia in chronic kidney disease.

Authors:  Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-01-29       Impact factor: 3.714

6.  Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study.

Authors:  Cathy Glass; Peggy Hipskind; Cynthia Tsien; Steven K Malin; Takhar Kasumov; Shetal N Shah; John P Kirwan; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2013-01-03

Review 7.  Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors.

Authors:  Manisha Jhamb; Steven D Weisbord; Jennifer L Steel; Mark Unruh
Journal:  Am J Kidney Dis       Date:  2008-06-24       Impact factor: 8.860

8.  Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.

Authors:  Mark D Deboer; Xinxia Zhu; Peter R Levasseur; Akio Inui; Zhaoyong Hu; Guofeng Han; William E Mitch; John E Taylor; Heather A Halem; Jesse Z Dong; Rakesh Datta; Michael D Culler; Daniel L Marks
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

9.  Aging and the energetic cost of life.

Authors:  Luigi Ferrucci; Jennifer A Schrack; Nicolas D Knuth; Eleanor M Simonsick
Journal:  J Am Geriatr Soc       Date:  2012-09       Impact factor: 5.562

10.  PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer.

Authors:  Serkan Kir; Hirotaka Komaba; Ana P Garcia; Konstantinos P Economopoulos; Wei Liu; Beate Lanske; Richard A Hodin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2015-12-06       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.